How DNA microarrays and expression profiling will affect clinical practice

BMJ

Volumn 319, Issue 7220, 1999, Pages 1306-

  Friend, Stephen H ^a  

^a ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; GENE PRODUCT;

DATA ANALYSIS; DIAGNOSTIC VALUE; DNA MICROARRAY; DRUG DEVELOPMENT; GENE EXPRESSION; MOLECULAR BIOLOGY; MONITORING; NOTE; PATIENT MONITORING; PRIORITY JOURNAL;

CLINICAL MEDICINE; DIAGNOSIS; DNA FINGERPRINTING; DRUG THERAPY; HUMANS;

EID: 0033552437     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.319.7220.1306     Document Type: Article

References (5)

1. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-470.
2. Jelinsky SA, Samson LD. Global response of S cerevesiae to an alkylating agent. Proc Natl Acad Sci USA 1999; 96: 1486-1491.
3. DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997: 680-6.
4. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998; 58: 5009-5013.
5. Marton M, DeRisi J, Bennett H, Iyer VR, Meyer Mr, Roberts CJ, et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nature Med 1998; 4: 1293-1301.